PHXHF(PHXHF)
PHXHF
No analyst ratings available
No analyst price targets available for PHXHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $736M | $808M | $841M |
| Low | $732M | $783M | $824M |
| High | $742M | $841M | $862M |
| EBITDA Avg | $122M | $134M | $140M |
| Low | $121M | $130M | $137M |
| High | $123M | $140M | $143M |
| EBIT Avg | $53M | $58M | $60M |
| Low | $53M | $56M | $59M |
| High | $53M | $60M | $62M |
| Net Income Avg | $41M | $68M | $80M |
| Low | $40M | $67M | $78M |
| High | $43M | $71M | $82M |
| EPS Avg | $0.90 | $1.48 | $1.73 |
| Low | $0.87 | $1.44 | $1.68 |
| High | $0.92 | $1.53 | $1.78 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $190M | $194M | $202M | $185M | $203M | $228M | $216M | $197M |
| Low | $190M | $194M | $202M | $185M | $203M | $228M | $216M | $197M |
| High | $190M | $194M | $202M | $185M | $203M | $228M | $216M | $197M |
| EBITDA Avg | $31M | $32M | $34M | $31M | $34M | $38M | $36M | $33M |
| Low | $31M | $32M | $34M | $31M | $34M | $38M | $36M | $33M |
| High | $31M | $32M | $34M | $31M | $34M | $38M | $36M | $33M |
| EBIT Avg | $14M | $14M | $15M | $13M | $15M | $16M | $16M | $14M |
| Low | $14M | $14M | $15M | $13M | $15M | $16M | $16M | $14M |
| High | $14M | $14M | $15M | $13M | $15M | $16M | $16M | $14M |
| Net Income Avg | $11M | $13M | $15M | $12M | $18M | $23M | $18M | $15M |
| Low | $11M | $13M | $15M | $12M | $18M | $23M | $18M | $15M |
| High | $11M | $13M | $15M | $12M | $18M | $23M | $18M | $15M |
| EPS Avg | $0.25 | $0.28 | $0.33 | $0.27 | $0.39 | $0.50 | $0.40 | $0.32 |
| Low | $0.25 | $0.28 | $0.33 | $0.27 | $0.39 | $0.50 | $0.40 | $0.32 |
| High | $0.25 | $0.28 | $0.33 | $0.27 | $0.39 | $0.50 | $0.40 | $0.32 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |